Experimentally induced and natural recovery from the effects of phenylalanine on brain protein synthesis.

PubWeight™: 0.88‹?›

🔗 View Article (PMID 245312)

Published in Biochim Biophys Acta on February 16, 1978

Authors

J V Hughes, T C Johnson

Articles by these authors

Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide. J Virol (1985) 5.73

Ribonucleic acid and protein synthesis in mitotic HeLa cells. J Cell Biol (1965) 1.98

Molecular cloning and partial sequencing of hepatitis A viral cDNA. J Virol (1985) 1.82

Neutralizing monoclonal antibodies to hepatitis A virus: partial localization of a neutralizing antigenic site. J Virol (1984) 1.78

High-titer adeno-associated viral vectors from a Rep/Cap cell line and hybrid shuttle virus. Hum Gene Ther (1998) 1.68

Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer. Science (1999) 1.57

Humoral immunity to adeno-associated virus type 2 vectors following administration to murine and nonhuman primate muscle. J Virol (2000) 1.57

Comparison of central nervous system disease produced by wild-type and temperature-sensitive mutants of vesicular stomatitis virus. Infect Immun (1976) 1.53

An NADP/thioredoxin system in leaves: purification and characterization of NADP-thioredoxin reductase and thioredoxin h from spinach. Arch Biochem Biophys (1988) 1.48

Route of administration determines induction of T-cell-independent humoral responses to adeno-associated virus vectors. Mol Ther (2000) 1.32

Vaginal douching in teenagers attending a family planning clinic. J Adolesc Health Care (1989) 1.17

A phase I study of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator gene to a lung segment of individuals with cystic fibrosis. Hum Gene Ther (1999) 1.16

Contrasting modes of photosynthetic enzyme regulation in oxygenic and anoxygenic prokaryotes. Arch Microbiol (1984) 1.14

Growth and maturation of a vesicular stomatitis virus temperature-sensitive mutant and its central nervous system isolate. J Virol (1979) 1.09

The rate of treatment of chronic hepatitis C in patients co-infected with HIV in an urban medical centre. J Viral Hepat (2005) 1.08

Synthesis and turnover of plasma-membrane proteins and glycoproteins in a neuroblastoma cell line. Biochem J (1976) 1.08

Role of E4 in eliciting CD4 T-cell and B-cell responses to adenovirus vectors delivered to murine and nonhuman primate lungs. J Virol (1998) 1.06

Cyclic loading of transosseous rotator cuff repairs: tension overload as a possible cause of failure. Arthroscopy (1997) 1.06

The uncoupled relationship between the temperature-sensitivity and neurovirulence in mice of mutants of vesicular stomatitis virus. J Gen Virol (1977) 1.03

An ultrastructural study of central nervous system disease produced by wild-type and temperature-sensitive mutants of vesicular stomatitis virus. Lab Invest (1976) 1.03

Status spongiousus resulting from intracerebral infection of mice with temperature-sensitive mutants of vesicular stomatitis virus. Br J Exp Pathol (1976) 1.02

An inactivated hepatitis A viral vaccine of cell culture origin. J Med Virol (1986) 0.99

Repeated administration of adenoviral vectors in lungs of human CD4 transgenic mice treated with a nondepleting CD4 antibody. J Immunol (1999) 0.98

The effects of phenylalanine on amino acid metabolism and protein synthesis in brain cells in vitro. J Neurochem (1976) 0.98

Keto/enol epoxy steroids as HIV-1 Tat inhibitors: structure-activity relationships and pharmacophore localization. J Med Chem (1995) 0.97

Spinal manipulation for primary and secondary dysmenorrhoea. Cochrane Database Syst Rev (2006) 0.96

Spinal manipulation for primary and secondary dysmenorrhoea. Cochrane Database Syst Rev (2001) 0.95

Regulation of protein synthesis in developing mouse brain tissue. Alteration in ribosomal activity. J Biol Chem (1970) 0.95

Thioredoxin system of the photosynthetic anaerobe Chromatium vinosum. J Bacteriol (1984) 0.95

The mechanism of polyribosome disaggregation in brain tissue by phenylalanine. Biochem J (1975) 0.94

Ultrastructural-immunohistochemical evidence for a maturation defect of temperature-sensitive G31 vesicular stomatitis virus in murine spinal cord neurons. Infect Immun (1979) 0.92

Infection of the central nervous system produced by mixtures of defective-interfering particles and wild-type vesicular stomatitis virus in mice. J Infect Dis (1977) 0.92

Characterization of cell-surface glycopeptides from mouse cerebral cortex that inhibit cell growth and protein synthesis. Biochem J (1980) 0.91

Inhibition of protein synthesis in noninfected L cells by partially purified interferon preparations. J Cell Biol (1968) 0.90

Ganglioside GM1 sensitizes tumor cells to growth inhibitory glycopeptides. Biochem Biophys Res Commun (1982) 0.90

In vivo assembly and maturation of vesicular stomatitis virus. Lab Invest (1976) 0.90

The effects of chronic hyperphenylalaninaemia on mouse brain protein synthesis can be prevented by other amino acids. Biochem J (1982) 0.90

The effects of maturation on in vitro protein synthesis by mouse brain cells. J Neurochem (1966) 0.88

Virus-induced demyelination. Production by a viral temperature-sensitive mutant. J Neurol Sci (1979) 0.88

The effects of hyperphenylalaninaemia on the concentrations of aminoacyl-transfer ribonucleic acid in vivo. A mechanism for the inhibition of neural protein synthesis by phenylalanine. Biochem J (1977) 0.87

Synthesis of RNA-polyadenylic acid by isolated brain nuclei. Science (1973) 0.87

Cell-free protein synthesis by mouse brain during early development. J Neurochem (1968) 0.87

Isolation of the glycoprotein of vesicular stomatitis virus and its binding to cell surfaces. J Gen Virol (1980) 0.87

The degradation and turnover of fucosylated glycoproteins in the plasma membrane of a neuroblastoma-cell line. Biochem J (1977) 0.87

Determination of 5-fluorouracil in human plasma by a simple and sensitive reversed-phase HPLC method. J Pharm Biomed Anal (1996) 0.87

Adenoviral-mediated suicide gene therapy for ovarian cancer. Mol Ther (2000) 0.86

Mass spectrometrically derived amino acid sequence of thioredoxin from Chlorobium, an evolutionarily prominent photosynthetic bacterium. J Biol Chem (1987) 0.86

Glycopeptides from brain inhibit rates of polypeptide chain elongation. J Biol Chem (1980) 0.86

Readministration of adenovirus vector in nonhuman primate lungs by blockade of CD40-CD40 ligand interactions. J Virol (2000) 0.85

Isolation and immunizations with hepatitis A viral structural proteins: induction of antiprotein, antiviral, and neutralizing responses. J Virol (1985) 0.85

Biology of E1-deleted adenovirus vectors in nonhuman primate muscle. J Virol (2001) 0.85

Neuroblastoma cell fusion by a temperature-sensitive mutant of vesicular stomatitis virus. J Virol (1979) 0.85

Hyperphenylalanemia: effect on brain polyribosomes can be partially reversed by other amino acids. Science (1977) 0.85

Inhibition of vesicular stomatitis virus glycoprotein expression by chloroquine. J Gen Virol (1982) 0.84

Regulation of protein synthesis during postnatal maturation of the brain. J Neurochem (1976) 0.84

Affinity labeling of the sialoglycopeptide antimitogen receptor. J Biol Chem (1987) 0.84

Isolation of cell-surface glycopeptides from bovine cerebral cortex that inhibit cell growth and protein synthesis in normal but not in transformed cells. Biochem J (1982) 0.84

Effect of alpha-methylphenylalanine and phenylalanine on brain polyribosomes and protein synthesis. J Neurochem (1981) 0.83

Subacute infection with temperature-sensitive vesicular stomatitis virus mutant G41 in the central nervous system of mice. II. Immunofluorescent, morphologic, and immunologic studies. J Infect Dis (1979) 0.83

The role of ribosomal ribonucleic acid in the structure and function of mammalian brain ribosomes. Biochem J (1974) 0.83

Maturation-dependent events related to DNA-dependent RNA synthesis in intact mouse brain nuclei. Brain Res (1972) 0.83

The effect of ribonuclease on ribosomal RNA and subsequent polypeptide synthesis. Biochem Biophys Res Commun (1973) 0.83

Alterations in peptide structure of vesicular stomatitis virus mutant and its central nervous system isolate. J Gen Virol (1981) 0.83

Purification and stability characterization of a cell regulatory sialoglycopeptide inhibitor. J Cell Biochem (1995) 0.83

Growth and metabolism of fucosylated plasma-membrane glycoproteins in mouse neuroblastoma N2a cells. Biochem J (1978) 0.82

The influence of advanced age on the outcome of assisted reproduction. J Assist Reprod Genet (1998) 0.82

Prevalence of seropositive reactions to Brucella canis in a limited survey of domestic cats. J Am Vet Med Assoc (1977) 0.82

Hypothermia-inducing peptide promotes recovery of vesicular stomatitis virus from persistent animal infections. J Virol (1985) 0.82

Incentives and their influence on appointment compliance in a teenage family-planning clinic. J Adolesc Health Care (1990) 0.82

Subacute infection with temperature-sensitive vesicular stomatitis virus mutant G41 in the central nervous system of mice. I. Clinical and virologic studies. J Infect Dis (1979) 0.82

Developmental alterations in RNA synthesis in isolated mouse brain nucleoli. Biochim Biophys Acta (1973) 0.81

Allograft safety: viral inactivation with bone demineralization. Contemp Orthop (1995) 0.81

Glycopeptides prepared from mouse cerebrum inhibit protein synthesis and cell division in baby hamster kidney cells, but not in their polyoma virus-transformed analogs. Exp Cell Res (1981) 0.81

Abnormal amino acid metabolism and brain protein synthesis during neural development. Neurochem Res (1978) 0.81

A cell surface glycoprotein virus inhibitor that is not interferon. Biochem Biophys Res Commun (1981) 0.81

Temporal relationship between virus and interferon biosynthesis in L cells infected with Newcastle disease virus. Proc Soc Exp Biol Med (1969) 0.81

An immune cell population that responds to beta-endorphin and is responsible for protecting nude mice from the fatal consequences of a virus infection of the central nervous system. J Neuroimmunol (1991) 0.80

Level and amino acid acceptor activity of mouse brain tRNA during neural development. J Neurochem (1973) 0.80

Mouse brain ribosomal subunits: role of ribosome-associated factors on aminoacyl-tRNA binding and polypeptide synthesis. Brain Res (1973) 0.80

Characteristics and products of a cell-free polypeptide synthesizing system from neonatal and adult mouse brain. J Neurochem (1972) 0.80

The effects of maturation on in vitro RNA synthesis by mouse brain cells. J Neurochem (1967) 0.80

Aminoacyl-RNA synthetase and transfer RNA binding activity during early mammalian brain development. J Neurochem (1969) 0.79

Purification and characterization of a cytostatic factor with anti-viral activity from the bitter melon. Prep Biochem (1983) 0.79

Virus protein assembly in microgravity. Adv Space Res (1993) 0.79

Beta-endorphin alters the course of central nervous system disease induced by a temperature-sensitive vesicular stomatitis virus in reconstituted nude mice. J Neuroimmunol (1990) 0.79

Tantalum air-interspace crossed grid: design and performance characteristics. Radiology (1982) 0.79

Stimulation of RNA synthesis in isolated mouse brain nuclei by a brain cytosol factor. Life Sci (1974) 0.79

Regulation of protein synthesis in developing mouse brain tissue: in vitro binding of template RNA to brain ribosomes. J Neurochem (1971) 0.79

Cytopathic effects in mouse neuroblastoma cells during a non-permissive infection with a mutant of vesicular stomatitis virus. J Gen Virol (1981) 0.78